(Q84240486)
Statements
Solubility advantage of amorphous pharmaceuticals, part 3: Is maximum solubility advantage experimentally attainable and sustainable? (English)
Sharad B Murdande
Michael J Pikal
Ravi M Shanker
scientific article published on 31 May 2011
No description defined